CGM Metrics
Cross-source consensus on CGM Metrics from 1 sources and 6 claims.
1 sources · 6 claims
Uses
How it works
Dosage & preparation
Highlighted claims
- Time Below Range is always addressed first in CGM data review because hypoglycemia carries the most immediate clinical risk. — Continuous Glucose Monitoring: A Clinical and Functional Medicine Guide
- The standard target for Time in Range is at least 70% of readings falling between 70 and 180 mg/dL. — Continuous Glucose Monitoring: A Clinical and Functional Medicine Guide
- Glucose Variability is measured as coefficient of variation, with a target below 36%. — Continuous Glucose Monitoring: A Clinical and Functional Medicine Guide
- The Glucose Management Indicator (GMI) estimates future lab A1C from CGM data and targets below 7%. — Continuous Glucose Monitoring: A Clinical and Functional Medicine Guide
- CGM active time should be at least 80% over a 10-day sensor wear period to produce meaningful data. — Continuous Glucose Monitoring: A Clinical and Functional Medicine Guide
- Reducing time spent outside the target glucose range automatically decreases overall glucose variability. — Continuous Glucose Monitoring: A Clinical and Functional Medicine Guide